Serum 25-hydroxyvitamin D is associated with islet function in postmenopausal women with type 2 diabetes and osteoporosis.

Authors

Xiuping Yin, Xiao Sun, Fang Gao, Xiaojie Wang, Peipei Chen, Xinxin Yang, Ningning Guo, Guangya Wang, Jinxiu Xu, Dongxia Fu

Published in

Frontiers in endocrinology. Volume 17. Pages 1850506. Epub Jun 03, 2026.

Abstract

To evaluate the association between serum 25-hydroxyvitamin D [25(OH)D] levels and islet function in postmenopausal women with type 2 diabetes mellitus (T2DM) and osteoporosis.
A total of 343 consecutively hospitalized postmenopausal women with type 2 diabetes mellitus and osteoporosis between December 2024 and December 2025 were included in the final analysis. Participants were classified into three groups according to serum 25(OH)D levels: sufficiency (>30 ng/mL), insufficiency (20-30 ng/mL), and deficiency (<20 ng/mL). Clinical characteristics, bone mineral density, and islet function-related indices were compared among the groups. Spearman correlation analysis and multivariable linear regression were performed to evaluate the associations between serum 25(OH)D levels and islet function.
No significant differences were found among the three groups in age, duration of T2DM, or glycated hemoglobin (HbA1c) (all P > 0.05), whereas body mass index (BMI) showed a marginal overall difference among the groups (P = 0.047). Lumbar spine, femoral neck, and total hip T-scores were progressively lower across groups with lower serum 25(OH)D levels (all P < 0.001). Fasting insulin (FINS), fasting C-peptide (FCP), homeostasis model assessment of β-cell function (HOMA-β), and homeostasis model assessment of insulin resistance (HOMA-IR) also showed significant intergroup differences (all P < 0.001). Serum 25(OH)D was positively correlated with fasting insulin, fasting C-peptide, and HOMA-β, but negatively correlated with HOMA-IR (all P < 0.001). Multivariable analysis showed that serum 25(OH)D remained associated with islet function and insulin resistance after adjustment for age, BMI, HbA1c, and T2DM duration.
In postmenopausal women with type 2 diabetes mellitus and osteoporosis, lower serum 25(OH)D levels were associated with poorer β-cell function, greater insulin resistance, and lower bone mineral density.

PMID:
42318225
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.